TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05561452

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single PRP Injection
Description: In single-PRP injection group, 10 ml of venous blood taken from the patients will be put into the T-LAB® PRP kit (T-Biotechnology Laboratory, İstanbul, Turkey) and will then be centrifuged at 3850 rpm for 8 minutes. Approximately 4 ml of the PRP obtained will be injected into the subacromial space using the lateral subacromial injection method under ultrasound guidance. All injections will be performed in the sagittal axis with the long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).~A physical therapy program including Codman pendulum exercises, shoulder range of motion, stretching and strengthening exercises will be given and be performed at least for 20 minutes daily.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multiple PRP Injections
Description: In multiple-PRP injection group, two PRP injections will be performed with an interval of 3 weeks. 10 ml of venous blood taken from the patients will be put into the T-LAB® PRP kit (T-Biotechnology Laboratory, İstanbul, Turkey) and will then be centrifuged at 3850 rpm for 8 minutes. Approximately 4 ml of the PRP obtained is planned to be injected into the subacromial space using the lateral subacromial injection method under ultrasound guidance. All injections will be performed in the sagittal axis with the long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).~A physical therapy program including Codman pendulum exercises, shoulder range of motion, stretching and strengthening exercises will be given and be performed at least for 20 minutes daily.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Placebo Injection
Description: In placebo-injection group,10 ml of venous blood will be taken and after the same waiting time 4 ml of 0.9% saline will be injected into the subacromial space using the lateral subacromial injection method under ultrasound guidance. All injections will be performed in the sagittal axis with the long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).~A physical therapy program including Codman pendulum exercises, shoulder range of motion, stretching and strengthening exercises will be given and be performed at least for 20 minutes daily.
Study: NCT06267131

Intervention type: DEVICE
Group type: OTHER
Intervention: Brain Pulse Oximeter
Description: Sensor is placed on the right and/or left forehead and maintained with an elasticized headband. The duration of monitoring will last for approximately 60 minutes per monitoring session to obtain sufficient data. Serial monitoring will occur on three consecutive days.
Study: NCT06555653

Intervention type: OTHER
Intervention: Video based multimedia information
Description: The intervention group was shown a 5 minute informational video before amniocentesis including definition of amniocentesis, its indications, the setup of amniocentesis room, the purpose and steps of the procedure, potential complications and how to manage them
Study: NCT05789485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: structured treadmill walking
Description: Three doses of AT (i.e., 90, 150, or 300 mins/week) will be tested. All doses will consist of individualized walking delivered up to 7 times per week delivered throughout treatment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: structured treadmill walking
Description: Three doses of AT (i.e., 90, 150, or 300 mins/week) will be tested. All doses will consist of individualized walking delivered up to 7 times per week delivered throughout treatment.
Study: NCT04790552

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fast Bar
Description: Subjects will be asked to consume a Fast Bar.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bar with Coffee
Description: Subjects will be asked to consume a Fast Bar with coffee.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bar with Tea
Description: Subjects will be asked to consume a Fast Bar with tea.
Study: NCT05789485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: structured treadmill walking
Description: Three doses of AT (i.e., 90, 150, or 300 mins/week) will be tested. All doses will consist of individualized walking delivered up to 7 times per week delivered throughout treatment.
Study: NCT01954472

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced portfolio plus structured exercise
Description: Foods on the dietary portfolio plan will contribute 9g/1000 kcal viscous fibre as β-glucan (oats, barley, oat bran breads and soups) and psyllium (cereal), 1g plant sterol/1000 kcal diet (in sterol margarine), 22.5g soy protein/1000 kcal (soy burgers, dogs, links, other soy meat analogues, soy milks, yogurts and cheese), and additional sources of plant protein from pulses (eg. Lentils, chickpeas, beans, etc) and 22.5g almonds or equivalent of other nuts/1000 kcal and increased MUFA (as olive and canola oils, avocados, nuts, margarine and salad dressings). The glycemic index will be reduced from 83 to 70 GI units (bread scale).~Exercise: The physical activity/exercise program is based on the program used at the Quebec Heart and Lung Institute.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: High fiber diet plus routine exercise
Description: Dietary advice will be given to encourage intake of whole grain foods (brown rice, whole wheat breads, muffins and breakfast cereals); to reduce meat consumption, choose low fat dairy products and a control margarine.~Exercise: A pamphlet (Canada's Physical Activity Guide, Health Canada) encouraging increased physical activity will be provided.
Study: NCT05318105

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aquadex Smartflow® System
Description: ultrafiltration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV Loop Diuretics
Description: diuretics
Study: NCT05562284

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: intra-arterial thrombolysis
Description: IAT introduces rt-PA directly into the ophthalmic circulation by super-selective microcatheterization.

Intervention type: OTHER
Group type: OTHER
Intervention: conservative treatments
Description: conservative treatments

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conservative treatments
Description: conservative treatments
Study: NCT04822272

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI thermometry
Description: MRI sequence of 5 to 10 minutes to measure the variation of temprerature in the prostate
Study: NCT05342818

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine
Description: will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron 8mg
Description: will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoclopramide Injection
Description: will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enteral feeding nutrition
Description: The type and rate of enteral feeding nutrition will be the same for all patients (180ml/3h). All patients have a 30-degree head-up position

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enteral feeding nutrition
Description: The type and rate of enteral feeding nutrition will be the same for all patients (180ml/3h). All patients have a 30-degree head-up position

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enteral feeding nutrition
Description: The type and rate of enteral feeding nutrition will be the same for all patients (180ml/3h). All patients have a 30-degree head-up position

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequential Organ Failure Assessment (SOFA) score
Description: SOFA score will be performed on all patients before the beginning of the study

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequential Organ Failure Assessment (SOFA) score
Description: SOFA score will be performed on all patients before the beginning of the study

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequential Organ Failure Assessment (SOFA) score
Description: SOFA score will be performed on all patients before the beginning of the study
Study: NCT04094948

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: dextrose-filled capsules
Study: NCT05457517

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YL-13027，Sintilimab
Description: YL-13027 combined with Sintilimab will be used as a cycle for 21 days. YLl-13027 is administered orally twice a day. Starting dose of YL-13027 is 240mg/d，with escalation to 360mg/d in phase Ib, and RP2D was administered orally twice a day in phase II.~Sindilizumab is administered intravenously 200mg every three weeks
Study: NCT05787002

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0780
Description: AZD0780 will be administered orally as a single dose after an overnight fast of at least 10 hours with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0780
Description: AZD0780 will be administered orally as a single dose after an overnight fast of at least 10 hours with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Rosuvastatin will be administered orally as a single dose after an overnight fast of at least 10 hours with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Rosuvastatin will be administered orally as a single dose after an overnight fast of at least 10 hours with approximately 240 mL of water.
Study: NCT05887947

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette Nicotine Concentration Order 5% 1.8% 5%
Description: At lab visit 1 participants receive 5% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 48 hours, at lab visit 2 participants receive 1.8% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 7 days, during phase two, participants received 5% electronic cigarette pod nicotine concentration for 6 weeks of home use.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette Nicotine Concentration Order 5% 1.8% 5%
Description: At lab visit 1 participants receive 5% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 48 hours, at lab visit 2 participants receive 1.8% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 7 days, during phase two, participants received 5% electronic cigarette pod nicotine concentration for 6 weeks of home use.
Study: NCT06341049

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intraperitoneal local anasthetic application + local anesthetic wound infiltration
Description: For Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltration, after the birth of the newborn and placenta, the uterus is taken out and closed, the blood accumulated in the pelvis is carefully wiped with surgical towels, and after complete hemostasis is achieved, sterilely prepared 20 ml 0.5% bupivacaine + 20 ml 2% lidocaine +1 A total of 40 ml of solution containing 200,000 epinephrine will be given to the surgeon. 10 ml of this solution will be instilled into all four quadrants of the uterus before closing the parietal peritoneum or fascia. The parietal peritoneal layer will be sutured or left open, depending on the surgeon's preference. 10 ml will be infiltrated around the edges of the rectus aponeurosis, and the remaining 20 ml will be infiltrated subcutaneously into the wound area.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intrathecal morphine application
Description: Group Morphine will be given 11.2 mg hyperbaric bupivacaine + 15 µg fentanyl + 150 µg morphine into the spinal space.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus lumborum block tip 1 application
Description: In Group Quadratus lumborum block, Quadratus lumborum block type I, a total of 40 ml of a solution containing 20 ml of 0.5% bupivacaine + 20 ml of 2% lidocaine + 1:200,000 epinephrine will be applied bilaterally under ultrasound guidance.
Study: NCT05506358

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: High performance liquid chromatography
Description: High performance liquid chromatography (HPLC) using the D10 System by Bio-Rad Laboratories will be used as the gold standard test.

Intervention type: DEVICE
Group type: OTHER
Intervention: Automated sickling test
Description: The standard sickling test using 2% sodium metabisulphite will be augmented using an automated microscope (such as Octopi) and machine learning, and will be used as one of the low-cost tests.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: HbS solubility test
Description: Standard HbS solubility test currently used in Nepal (e.g. Sicklevue) will be used as one of the low-cost tests

Intervention type: DEVICE
Group type: OTHER
Intervention: HemoTypeSC
Description: A point-of-care lateral flow assay, HemoTypeSC (https://www.hemotype.com/), will be used as one of the low-cost tests

Intervention type: DEVICE
Group type: OTHER
Intervention: Sickle SCAN
Description: A point-of-care lateral flow assay, Sickle SCAN (https://www.biomedomics.com/products/hematology/sicklescan/), will be used as one of the low-cost tests

Intervention type: DEVICE
Group type: OTHER
Intervention: Gazelle Hb Variant Test
Description: A portable electrophoresis machine, Gazelle diagnostic device (https://hemexhealth.com/), will be used as one of the low-cost tests
Study: NCT06256965

Intervention type: DIAGNOSTIC_TEST
Intervention: Detection of peri-operative atrial fibrillation
Description: atrial tissue and plasma from patients with atrial fibrillation detection were analyzed for determine lipid and protein oxidation, and detect markers of myocardial injury.
Study: NCT05626699

Intervention type: DEVICE
Group type: OTHER
Intervention: RT Assistant
Description: RRT's will be given the RT Assistant to use during a regular ICU shift to make patient care decisions.
Study: NCT05702879

Intervention type: DRUG
Intervention: Ozanimod
Description: Start of standard therapy
Study: NCT06360107

Intervention type: OTHER
Group type: OTHER
Intervention: brief video
Description: brief video about depression

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: brief video
Description: brief video about depression

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: brief video
Description: brief video about depression
Study: NCT05713461

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise training program
Description: Adapted Interval Training Intervention, three days a week, 10 weeks.~Warm-up 10': Joint mobility and cardiovascular activation~Main part:~Resistance training circuit for strengthening the main muscle groups.~Cool down Flexibility and CORE
Study: NCT05702879

Intervention type: DRUG
Intervention: TNF Inhibitor
Description: Start of standard therapy

Intervention type: DRUG
Intervention: Steroids
Description: Start of standard therapy

Intervention type: DRUG
Intervention: Vedolizumab
Description: Start of standard therapy

Intervention type: DRUG
Intervention: Ustekinumab
Description: Start of standard therapy
Study: NCT02917226

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical decision support and monitoring system
Study: NCT05713461

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise training program
Description: Adapted Interval Training Intervention, three days a week, 10 weeks.~Warm-up 10': Joint mobility and cardiovascular activation~Main part:~Resistance training circuit for strengthening the main muscle groups.~Cool down Flexibility and CORE

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feeding training
Description: Two workshops on healthy eating habits (Week 1 and week 5). Food Frequency Questionnaires (weekly). Feedback weekly. Mediterranean Diet Adherence Screener (MEDAS). The dietary intervention will be based on the nutritional recommendations based on the Mediterranean diet, according to the evidence from the PREDIMED trial.
Study: NCT05713461

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feeding training
Description: Two workshops on healthy eating habits (Week 1 and week 5). Food Frequency Questionnaires (weekly). Feedback weekly. Mediterranean Diet Adherence Screener (MEDAS). The dietary intervention will be based on the nutritional recommendations based on the Mediterranean diet, according to the evidence from the PREDIMED trial.
Study: NCT06122441

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complex lifestyle intervention
Description: The complex lifestyle intervention comprise high-intensity aerobic and strength exercise, behavioral counselling based on Acceptance and Commitment Theory (ACT), and dietary counselling based on Norwegian nutritional guidelines. The different intervention elements are introduced step-wise to reduce initial overload. Participants are progressively transitioned over to the Tromsø municipality and local NGO's, who delivers activities harmonized with the intervention elements. Participants are at this stage also supported by an eTool which digitally reinforces the intervention through web-based information and videos.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity monitoring and recommendations
Description: Wrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity monitoring and recommendations
Description: Wrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health.
Study: NCT06011083

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
Description: using topical ointment containing calcipotriol and betamethasone dipropionate for plaque psoriasis.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
Description: using topical ointment containing calcipotriol and betamethasone dipropionate for plaque psoriasis.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional carbon dioxide (CO2) laser
Description: fractional CO2 laser sessions once per month for 3 months over a similar psoriatic plaque
Study: NCT05700825

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Expiratory Muscle Strength Training + Cough Skill Training
Description: Expiratory Muscle Strength Training (EMST). EMST is a widely used and efficacious treatment approach that uses a calibrated device with a one-way, spring-loaded pressure relief valve to mechanically overload the expiratory and submental muscles.~Cough Skill Training (CST) involves a digital peak flow meter device which measures PEFR (peak expiratory flow rate) in liters/second and allows patients to receive immediate biofeedback.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expiratory Muscle Strength Training + Cough Skill Training
Description: Expiratory Muscle Strength Training (EMST). EMST is a widely used and efficacious treatment approach that uses a calibrated device with a one-way, spring-loaded pressure relief valve to mechanically overload the expiratory and submental muscles.~Cough Skill Training (CST) involves a digital peak flow meter device which measures PEFR (peak expiratory flow rate) in liters/second and allows patients to receive immediate biofeedback.
Study: NCT06371196

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Babaodan Capsule
Description: Babao Dan Capsule (State Drug License: Z10940006) is produced by Xiamen Traditional Chinese Medicine Factory Co., Ltd; Packing specification: 0.3g/capsule, 6 capsules/board×2 boards/small box; Ingredients are in vitro cultivated cowhide, snake gallbladder, antelope horn, pearl, panax ginseng, artificial musk, and so on. Intervention measures are really the original UDCA treatment program based on the addition of eight treasure Dan capsule, 2 capsules / times, tid, oral. Course of treatment: 3 months (based on 30 days/month).
Study: NCT04129658

Intervention type: BEHAVIORAL
Intervention: Educational outreach visit
Description: Two-four hours of discussion between a cardiologist and the primary care physicians at the PHCC encompassing evidence-based treatment guidelines and counseling upon specific patient cases and their diagnose and treatment for congestive heart failure.
Study: NCT05675891

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supplemental Feeding System Group
Description: The body weight is measured in the morning fasting on the day when oral feeding is decided, 3 feeding between 08-16:00 are carried out with the supplemental feeding system, The amount of food prepared is recorded, Heart rate, oxygen saturation, respiratory rate and early feeding skill score are recorded before, during and after feeding, When the feeding is finished, the total amount of food taken by the baby and the feeding time are recorded, The rate of food intake (%) and the amount of food received per minute are calculated and recorded, Infants who can take 80% of the amount of food given at each meal by being fed orally for 8 meals two days in a row are considered to have switched to full oral feeding.
Study: NCT05053347

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flaxseed oil capsule
Description: The participants were asked to take flaxseed oil capsule 5d/day(ALA 2.5g/d). The intervention period is about 6 months separated by a one-month washout period. Do not take any other medicine, traditional Chinese medicine, or dietary supplements.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Corn oil capsule
Description: The participants were asked to take corn oil capsule 5d/day. The intervention period is about 6 months separated by a one-month washout period. Do not take any other medicine, traditional Chinese medicine, or dietary supplements.
Study: NCT03668821

Intervention type: OTHER
Intervention: Questionnaire
Description: Quality of life and frailty questionnaires

Intervention type: OTHER
Intervention: Questionnaire
Description: Quality of life and frailty questionnaires

Intervention type: OTHER
Intervention: Questionnaire
Description: Quality of life and frailty questionnaires